Hetero Labs Limited Irbesartan Export Data — India (DGFT 2022–2026)

Name: Hetero Labs Limited Irbesartan Export Records India — #15 Exporter, 35 Shipments, $1.0M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irbesartan

India Pharmaceutical Trade Intelligence

$106.3M123 Suppliers68 CountriesHS 30049079

ExportsIndia → UNITED STATES37.2%India → FRANCE15.4%

ImportsSPAIN → India$149.9K UNITED STATES → India$19.2K

#1 Buyer: MACLEODS PHARMA

Hetero Labs Limited — Irbesartan Exporter #15 | $1.0M Trade Value | TransData Nexus | TransData Nexus

Hetero Labs Limited — Irbesartan Exporter Profile

Indian Pharmaceutical Exporter · #15 for Irbesartan · $1.0M export value · DGFT Verified

Hetero Labs Limited is the #15 Indian exporter of Irbesartan with $1.0M in export value and 35 verified shipments. Hetero Labs Limited holds a 1.0% market share in Irbesartan exports across 8 countries. The company exports 46 pharmaceutical products worth $319.3M across 18 therapeutic categories.

Hetero Labs Limited — Irbesartan Export Profile: Buyers & Destinations

Hetero Labs Limited Irbesartan export treemap — buyers and destination countries | TransData Nexus

Where Does Hetero Labs Limited Export Irbesartan?

Country	Value	Shipments	Share
UNITED STATES OF AMERICA	$632.4K	13	76.3%
COLOMBIA	$50.0K	1	6.0%
UNITED KINGDOM	$47.4K	2	5.7%
NICARAGUA	$44.5K	7	5.4%
TANZANIA	$41.3K	4

Who Are the Top Buyers of Irbesartan from Hetero Labs Limited?

Buyer	Country	Value	Orders
XXMBEXXPHAXXACEXXICAXX IXX	UNITED STATES OF AMERICA	$632.4K	13
TO THE ORDER OF	TANZANIA	$78.4K	3
XXAROXXLIMXXED	UNITED KINGDOM	$47.4K	2
TO THE ORDER OF ...	NICARAGUA	$23.1K	3
TO THE ORDER OF ,	NICARAGUA	$13.2K	2
TO THE ORDER OF.	TANZANIA	$12.9K	2
TO THE ORDER	NICARAGUA	$10.4K	8
XXAROXXPHAXXA XXA XX C XX	MEXICO	$6.9K	1
XXAROXXPHAXXA BXX	NETHERLANDS	$4.0K	1

Hetero Labs Limited supplies Irbesartan to 9 buyers globally. The largest buyer is XXMBEXXPHAXXACEXXICAXX IXX (UNITED STATES OF AMERICA), followed by TO THE ORDER OF (TANZANIA) and XXAROXXLIMXXED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irbesartan Formulations Does Hetero Labs Limited Export?

Product Description / Formulation	Value	Shipments
IRBESARTAN 300MG TABLETS	$306.9K	7
IRBESARTAN 150MG TABLETS (1X90'S)	$185.5K	4
IRBESARTAN 150MG TABLETS	$101.0K	3
IRBESARTAN 300MG TABLETS (1X90'S)	$50.0K	1
IRBIGEN IRBESARTAN TABLET	$50.0K	1
IRBESARTAN 75MG TABLETS (2X14'S)	$47.4K	2
IRBIS IRBESARTAN TAB 9940 BOX 298200 TAB FREE UNITS994 BOX 29820 TA BATCH NO ITR250101 MFG DT 01 25 EXP DT 12 26	$23.7K	1
IRBESARTAN TABLET (QTY: 8,718 BOX) (PACK OF 30'S)	$13.7K	1
IRBESARTAN 300 MG TABS (Pack of 30 s) (	$13.2K	2
IRBIS IRBESARTAN TABLET 10S (135900 TABLET)NOS	$12.9K	1

Hetero Labs Limited exports 19 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is IRBESARTAN 300MG TABLETS with 7 shipments worth $306.9K.

How Does Hetero Labs Limited Compare to Nearest Irbesartan Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	AUROBINDO PHARMA LIMITED	$1.2M	109	3	$11.2K
14	MEPRO PHARMACEUTICALS PRIVATE LIMITED	$1.0M	71	1	$14.8K
15	HETERO LABS LIMITED ★	$1.0M	35	8	$29.3K
10	MEDICO REMEDIES LIMITED	$800.0K	16	2	$50.0K

Hetero Labs Limited ranks #15 among 123 Indian Irbesartan exporters. Average shipment value of $29.3K compared to the market average of $473.0K. The closest competitors by value are AUROBINDO PHARMA LIMITED and MEPRO PHARMACEUTICALS PRIVATE LIMITED.

Which Indian Ports Ship Irbesartan Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	284	10.6%
SAHAR AIR	197	7.4%
SAHAR AIR CARGO ACC (INBOM4)	170	6.4%
JNPT/ NHAVA SHEVA SEA	147	5.5%
DELHI AIR	135	5.1%
DELHI AIR CARGO ACC (INDEL4)	133	5.0%
JNPT	129	4.8%
MUNDRA SEA (INMUN1)	108	4.0%

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Irbesartan Exports

The current geopolitical climate presents both challenges and opportunities for Hetero Labs Limited. The Israel-Iran tensions have led to increased risks in the Red Sea shipping routes, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts Indian pharmaceutical exporters like Hetero, potentially eroding profit margins and necessitating strategic adjustments in logistics and pricing strategies.

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. The U.S. has imposed tariffs as high as 245% on APIs from certain countries, leading to a reshoring of pharmaceutical manufacturing. Indian firms, including Hetero, have responded by investing in U.S. facilities, with outbound foreign direct investment estimated between $500-700 million during the partial FY 2025-26. This strategic move not only circumvents tariffs but also strengthens Hetero's presence in the lucrative U.S. market.

The recent India-European Union Free Trade Agreement (FTA), concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU. This development enhances Hetero's competitiveness in the European market, providing a significant boost to its export potential. However, compliance with the EU's Falsified Medicines Directive remains imperative, necessitating stringent quality controls and traceability measures to maintain market access.

Hetero Labs Limited — Regulatory Compliance & Quality Standards

Regulatory compliance is paramount for Hetero's sustained success in international markets. In October 2025, the U.S. Food and Drug Administration (FDA) issued a Form 483 to Hetero's Nakkapalli facility in Andhra Pradesh, citing six major compliance lapses, including quality control deficiencies and improper documentation practices. Such observations can jeopardize Hetero's ability to supply APIs and antiretroviral drugs to the U.S. market, underscoring the critical need for rigorous adherence to Good Manufacturing Practices (GMP) and prompt corrective actions to address regulatory concerns.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Hetero Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 35 individual customs records matching Hetero Labs Limited exporting Irbesartan, covering 19 formulations to 8 countries via 9 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 68+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irbesartan

Irbesartan

Hetero Labs Limited — Irbesartan Exporter Profile

Hetero Labs Limited — Irbesartan Export Profile: Buyers & Destinations

Where Does Hetero Labs Limited Export Irbesartan?

Who Are the Top Buyers of Irbesartan from Hetero Labs Limited?

What Is India's Total Irbesartan Export Value and How Much Does Hetero Labs Limited Contribute?

What Is the Average Shipment Value for Hetero Labs Limited's Irbesartan Exports?

How Does Hetero Labs Limited Compare to Other Indian Irbesartan Exporters?

What Irbesartan Formulations Does Hetero Labs Limited Export?

Regulatory Requirements: Exporting Irbesartan to Key Markets

United Kingdom — MHRA

How Does Hetero Labs Limited Compare to Nearest Irbesartan Exporters?

Which Indian Ports Ship Irbesartan Exports?

Geopolitical & Trade Policy Impact on Hetero Labs Limited's Irbesartan Exports

Hetero Labs Limited — Regulatory Compliance & Quality Standards

About Hetero Labs Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irbesartan Export Data from Hetero Labs Limited

Irbesartan Stats

Company Overview

Top Products by Hetero Labs Limited

Related Analysis

Need Detailed Export Data?

Data Source